The nation’s drug shortage crisis continues to affect cancer patients and survivors with 1 in every 10 (10%) reporting impacts to care, a majority of whom have had difficulties finding substitute medications (68%) and cited treatment delays (59%). The data is part of a new survey by the American Cancer Society Cancer Action Network (ACS CAN).
According to a new survey, half of Lesbian, Gay, Bisexual, Transgender, and Queer/Questioning (LGBTQ+) cancer patients and survivors report they are concerned they may face discrimination in a health care setting. More than one-third have experienced discrimination in a health care setting due to their sexual orientation or gender identity, and 75% of those who say they experienced discrimination feel it impacted their health care.
La mayoría (58%) de los pacientes y sobrevivientes de cáncer dicen que sería menos probable que se mantuvieran al día con la atención preventiva recomendada si tuviera un costo, según una nueva encuesta realizada por la Red de Acción Contra el Cáncer de la Sociedad Americana Contra el Cáncer (ACS CAN).
According to the most recent Survivor Views survey, cost is considered the most important factor when it comes to comparing coverage options (43%), but the right mix of covered benefits is also essential.
Female cancer patients are less satisfied with the quality of their cancer care than male cancer patients and are more likely to report that their symptoms were not taken seriously and that they had to prove their symptoms to providers.
Albany, NY - Una nueva encuesta "Survivor Views" (Opiniones de sobrevivientes) de la Red de Acción Contra el Cáncer de la Sociedad Americana Contra el Cáncer (ACS CAN) muestra que, si bien los programas de asistencia para copagos pueden ayudar a los pacientes con cáncer a pagar los medicamentos que necesitan, algunos no pueden aplicarlos al deducible de su cobertura de salud ni a otros requisitos de gastos de bolsillo, lo que puede crear una barrera para la atención.
An article released today in JAMA Network Open details the potential benefits of using technology to increase patient participation in cancer clinical trials. In a survey of nearly 1,200 recent cancer patients and survivors, more than 80% said they would be willing to use remote technologies and tools in a trial.
The cost of cancer care is substantially impacting the lives of cancer patients and survivors, forcing them to make significant lifestyle changes, and causing some to incur long-term medical debt.
The majority of cancer patients in the United States say they struggle to afford the costs of their cancer care.
Una nueva encuesta proporciona información sobre cómo un programa nacional de licencia familiar y médica remunerada podría beneficiar a los pacientes y sobrevivientes de cáncer que se enfrentan con el absentismo laboral y la pérdida de ingresos debido a su enfermedad.